Biocity Biopharmaceutics Co., Ltd.

This is a first-in-human study to find a safe dose and check early signs of effectiveness for a new drug called BC2027. It is for adults with advanced solid tumors (like lung or liver cancer) that have worsened despite standard treatments. The study will first test increasing dos…